1. Dai, Guihong, Guo, Zhongying, Chen, Huiping, Yu, Hong, Huang, Junxing. . High expression of guanine nucleotide-binding protein-like-3-like is associated with poor prognosis in esophageal cancer. In Medicine, 100, e25993. doi:10.1097/MD.0000000000025993. https://pubmed.ncbi.nlm.nih.gov/34032716/
2. Liu, Pei, Guo, Wenjia, Su, Ying, Chen, Cheng, Lv, Xiaoyi. 2022. Multi-Omics Analysis of GNL3L Expression, Prognosis, and Immune Value in Pan-Cancer. In Cancers, 14, . doi:10.3390/cancers14194595. https://pubmed.ncbi.nlm.nih.gov/36230520/
3. Cai, Qian, Chen, Sirui, Zhu, Yingqun, Li, Zhe. 2023. Knockdown of GNL3L Alleviates the Progression of COPD Through Inhibiting the ATM/p53 Pathway. In International journal of chronic obstructive pulmonary disease, 18, 2645-2659. doi:10.2147/COPD.S424431. https://pubmed.ncbi.nlm.nih.gov/38022822/
4. Lin, Tao, Meng, Lingjun, Lin, Tsung-Chin, Pederson, Thoru, Tsai, Robert Y L. 2014. Nucleostemin and GNL3L exercise distinct functions in genome protection and ribosome synthesis, respectively. In Journal of cell science, 127, 2302-12. doi:10.1242/jcs.143842. https://pubmed.ncbi.nlm.nih.gov/24610951/
5. Yasumoto, Hiroaki, Meng, Lingjun, Lin, Tao, Zhu, Qubo, Tsai, Robert Y L. 2007. GNL3L inhibits activity of estrogen-related receptor gamma by competing for coactivator binding. In Journal of cell science, 120, 2532-43. doi:. https://pubmed.ncbi.nlm.nih.gov/17623774/
6. Meng, L, Hsu, J K, Tsai, R Y L. 2010. GNL3L depletion destabilizes MDM2 and induces p53-dependent G2/M arrest. In Oncogene, 30, 1716-26. doi:10.1038/onc.2010.550. https://pubmed.ncbi.nlm.nih.gov/21132010/
智鼠故事 
